ClearPoint Neuro
CLPT
81 hedge funds and large institutions have $51.3M invested in ClearPoint Neuro in 2024 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 22 increasing their positions, 21 reducing their positions, and 7 closing their positions.
204% more call options, than puts
Call options by funds: $817K | Put options by funds: $269K
143% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 7
17% more capital invested
Capital invested by funds: $43.8M → $51.3M (+$7.41M)
14% more funds holding
Funds holding: 71 → 81 (+10)
1.71% more ownership
Funds ownership: 26.22% → 27.94% (+1.7%)
5% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 21
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$2.31M |
| 2 |
CM
CM Management
Gulf Breeze,
Florida
|
+$1.22M |
| 3 |
AIC
AWM Investment Company
New York
|
+$919K |
| 4 |
LCM
Legato Capital Management
San Francisco,
California
|
+$914K |
| 5 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
+$524K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$1.19M |
| 2 |
RA
Royce & Associates
New York
|
-$167K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$163K |
| 4 |
Stifel Financial
St. Louis,
Missouri
|
-$132K |
| 5 |
JP Morgan Chase
New York
|
-$109K |
CLPT Hedge Fund Activity: Q1 2024 in Review
81 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in ClearPoint Neuro (CLPT) for Q1 2024, worth a combined $51.3M — up 17% from $43.8M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new CLPT positions and 7 closed out — a net gain of 10 holders — while 22 added to existing stakes and 21 trimmed.
The largest buyer was Essex Investment Management, opening a new position worth an estimated $2.31M. The largest seller was Morgan Stanley, cutting an estimated $1.19M.
- 81 institutional investors held ClearPoint Neuro (CLPT) as of Q1 2024, up from 71 in Q4 2023.
- Funds reported $51.3M of ClearPoint Neuro stock for Q1 2024, up 17% quarter-over-quarter.
- 17 funds opened new ClearPoint Neuro positions in Q1 2024 and 7 closed out, a net change of +10 holders.
- The largest ClearPoint Neuro buyer in Q1 2024 was Essex Investment Management, an estimated $2.31M added.
- The largest ClearPoint Neuro seller in Q1 2024 was Morgan Stanley, an estimated $1.19M sold.
Based on aggregated 13F filings for Q1 2024.